Cargando…
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune and degenerative disease with axonal damage and demyelination as its main features. Its dual neurological and autoimmune nature makes it a disease that is difficult to treat. Treatments that simultaneously stop the immune response while...
Autores principales: | Benítez-Fernández, Rocio, Gil, Carmen, Guaza, Carmen, Mestre, Leyre, Martínez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694690/ https://www.ncbi.nlm.nih.gov/pubmed/36430856 http://dx.doi.org/10.3390/ijms232214378 |
Ejemplares similares
-
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020) -
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
por: Mecha, Miriam, et al.
Publicado: (2013) -
Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
por: Mestre, Leyre, et al.
Publicado: (2021) -
Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
por: Mestre, Leyre, et al.
Publicado: (2019) -
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
por: Mestre, Leyre, et al.
Publicado: (2020)